Geneva, July 7 -- International Clinical Trials Registry received information related to the study (NCT07660055) titled 'Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors' on June 15.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Novartis Pharmaceuticals
Condition:
Breast Cancer
Non-small Cell Lung Cancer (NSCLC)
Gastric/Gastroesophageal Junction (GEJ) Cancer
Bladder Cancer
Intervention:
Diagnostic Test: [68Ga]Ga-DWJ155
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: June 16, 2026
Target Sample Size: 156
Countries of Recruitment:
Austra...